 | Seelos Therapeutics, Inc. | |||
| NCM : SEEL || Location: United States | ||||
$0.29-0.01 (-4.23%) |
0.3 M | 0.28 - 0.3 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.727 M |
| March 15, 2024 | 0.815 M |
| Feb. 29, 2024 | 0.293 M |
| Feb. 15, 2024 | 0.310 M |
| Jan. 31, 2024 | 0.409 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.82 | -0.79 | 3.19% |
| 09/30/2023 | -1.84 | -3.60 | -96.08% |
| 06/30/2023 | -2.86 | -6.60 | -131.10% |
| 03/31/2023 | -3.37 | -3.60 | -6.95% |
| 12/31/2022 | -3.98 | -5.10 | -28.21% |
SEEL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 13.681M | Shares Float | 13.401M |
| Short Float | 0.727M | Market Cap | 4.10M |
| Institution ownership | 23.56% | Insider ownership | 2.002% |
| Earnings Date | 05/13/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -7.73 | Forward EPS | -1.31 |